Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms
间充质干细胞治疗通过多种免疫调节机制改善新冠肺炎患者的预后
期刊:Cellular Signalling
影响因子:28.1
doi:10.1038/s41422-021-00573-y
Rongjia Zhu #,Tingdong Yan #,Yingmei Feng #,Yan Liu #,Hongcui Cao #,Gongxin Peng #,Yanlei Yang,Zhen Xu,Jingqi Liu,Wei Hou,Xiaoyue Wang,Zhe Li,Luchan Deng,Shihua Wang,Jing Li,Qin Han,Hongling Li,Guangliang Shan,Yinghao Cao,Xingyan An,Jianshe Yan,Zhonghui Zhang,Huafei Li,Xuebin Qu,Jiaqi Zhu,Shumin Zhou,Jiao Wang,Fengchun Zhang,Jinming Gao,Ronghua Jin,Dayong Xu,Yan-Qing Ma,Tao Huang,Shuang Peng,Zhi Zheng,Ilia Stambler,Eric Gilson,Lee Wei Lim,Alexey Moskalev,Antonio Cano,Sasanka Chakrabarti,Brun Ulfhake,Huanxing Su,Haoying Xu,Sihuan Xu,Feng Wei,Holly M Brown-Borg,Kyung-Jin Min,Georgina Ellison-Hughes,Calogero Caruso,Kunlin Jin,Robert Chunhua Zhao
新冠
肺炎
细胞生物学
发育与干细胞
炎症/感染
免疫/内分泌
干细胞
